Mid Coast Hospital Skin Cancer Screening Reveals Cancer Risk

Mid Coast Hospital Skin Cancer Screening Reveals Cancer Risk

Potentially life-threatening cancers identified in 8% of participants

BRUNSWICK, ME – Each year, Mid Coast Hospital holds a community skin cancer screening aimed at promoting early detection and prevention of skin cancer. Offered at no cost to the public, this year’s event was held on Saturday, May 13, 2017. Of the 129 individuals screened, 87 had positive findings and were educated on continued monitoring. The screening identified 30 individuals who were referred for follow-up care and potentially life-threatening cancers in 8% of participants.

“Skin cancer is the most common form of cancer with more than one million new cases reported every year,” said Brunswick-based dermatologist Dr. Helge Riemann. “The good news is that skin cancer is preventable and treatable through good sun-safety habits and early detection.”

The screening was a collaboration of The American Academy of Dermatology, the American Cancer Society, Mid Coast Hospital’s Center for Community Heath & Wellness, and Mid Coast-affiliated dermatology experts.

According to the American Academy of Dermatology, one in five Americans will be diagnosed with some form of skin cancer in their lifetime, making it the most common cancer in the United States.

Dr. Riemann continued, “You can take action to prevent skin cancer and reduce the risk of UV damage by limiting your time in the sun, using sunscreen (SPF 30 or higher), covering exposed skin, and checking your skin regularly for changes.”

###

About Mid Coast Hospital

Mid Coast Hospital is a full-service, 93-bed, independent, not-for-profit hospital governed by a community Board of Directors. The active medical staff includes more than 200 providers in over 30 primary care and specialty areas. Mid Coast Hospital is accredited by The Joint Commission, and is recognized as a Magnet™ facility by the American Nurses Credentialing Center for exceptional nursing and patient care.

Confidentiality Notice: This email message, including any attachments, is for the use of the intended recipient(s) only and may contain information that is privileged, confidential, and prohibited from unauthorized disclosure under applicable law. If you are not the intended recipient of this message, any dissemination, distribution, or copying of this message is strictly prohibited. If you received this message in error, please notify the sender by reply email and destroy all copies of the original message and attachments.